Candice D. Johnson is an associate in the Denver office of Gibson, Dunn & Crutcher. She currently practices in the firm’s Corporate Department.  Candice’s practice is focused on capital markets transactions and mergers & acquisitions, and includes representation of clients in connection with corporate governance and Exchange Act reporting matters.

Selected Transactions

• Initial Public Offering of Shattuck Labs, Inc., counsel to the Issuer
• Initial Public Offering of Viant Technology Inc., counsel to the Issuer
• Initial Public Offering of Zevia PBC, counsel to the Issuer
• Follow-on equity offerings of Odonate Therapeutics, Inc., 89bio, Inc. and Progenity, Inc., counsel to the Issuer
• Over $10 billion in public offerings of senior notes of Wells Fargo & Company, counsel to the underwriters
• At-the-market equity offerings of Biora Therapeutics, Inc., CTI BioPharma Corp., Shattuck Labs, Inc., and 89bio, Inc., counsel to the Issuer
• $850 million purchase of Empire City Casino and Yonkers Raceway by MGM Resorts, counsel to the buyer
• $825 million sale of Circus Circus Las Vegas by MGM Resorts, counsel to the seller
• $35 million purchase of Palamedrix, Inc. by SomaLogic, Inc., counsel to the buyer

Candice earned her Juris Doctor from the University of Virginia School of Law in 2018. During law school, she served as a member of the editorial board for the Journal of Law and Politics and was twice selected to be part of the competitive Peer Advisor program. She also served as President of the Law Christian Fellowship. Candice earned her Bachelor of Arts degree, summa cum laude, with a double major in History and Philosophy, Politics, Economics, & Law and a minor in English from the University of Arizona in 2014. She graduated with honors and was elected to Phi Beta Kappa.

Candice is admitted to practice law in the states of California and Colorado.